Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Implementation01:15

Nursing Implementation

6.1K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
6.1K
Sustainable Development01:43

Sustainable Development

15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K
Therapeutic Index01:13

Therapeutic Index

6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Therapeutic Communication01:30

Therapeutic Communication

7.9K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.9K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.1K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease Outcomes in Boys with <i>ABCD1</i> Variants Identified by Newborn Screening for X-ALD.

medRxiv : the preprint server for health sciences·2026
Same author

Normative modeling for quantitative brain MRI phenotyping and biomarker discovery for pediatric leukodystrophies.

medRxiv : the preprint server for health sciences·2026
Same author

Provider Perceptions of the Impact of Rapid Whole Genome Sequencing on Care and Management.

Research square·2026
Same author

BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy.

American journal of human genetics·2026
Same author

Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup.

Neuromuscular disorders : NMD·2026
Same author

Message From the Editors to Our Reviewers: 2025.

Neurology. Genetics·2026

Related Experiment Video

Updated: Jan 28, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.8K

Development, Implementation, and Use of a Neurology Therapeutics Committee.

Edward B Clark1, Russell J Butterfield2,3, Francis M Filloux2,3

  • 1University of Utah Medical Group, University of Utah School of Medicine, Salt Lake, UT, USA.

Child Neurology Open
|February 26, 2019
PubMed
Summary

A new Neurology Therapeutics Committee helps personalize pediatric neurological treatments, ensuring appropriate use and managing costs. This approach aims to improve patient care and support for families facing rare diseases.

Keywords:
gene therapynusinersenpediatric neurologyspinal muscular atrophytherapeutics

More Related Videos

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

5.7K
Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram
06:12

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

11.1K

Related Experiment Videos

Last Updated: Jan 28, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.8K
Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

5.7K
Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram
06:12

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

11.1K

Area of Science:

  • Pediatric Neurology
  • Pharmacoeconomics
  • Healthcare Management

Background:

  • Innovative therapeutics offer new hope for children with previously untreatable neurological disorders.
  • Clinical implementation faces challenges including variable efficacy, administration tolerance, complex therapy matching, and high costs.
  • These challenges create financial burdens for families, insurers, and the healthcare system.

Purpose of the Study:

  • To address challenges in the clinical implementation of novel therapeutics for pediatric neurological disorders.
  • To develop a personalized process for matching patients with appropriate therapies.
  • To assist third-party payers in approving therapeutic use based on safety and efficacy.

Main Methods:

  • Establishment of a dedicated Neurology Therapeutics Committee for pediatric patients.
  • Review of the committee's operational mechanisms and processes.
  • Description of the committee's application in clinical practice.

Main Results:

  • The committee facilitates personalized treatment selection for pediatric neurological conditions.
  • It encourages appropriate use of therapeutics, mitigating clinician pressure for universal prescription.
  • The committee aids third-party payers in evaluating safety and efficacy for treatment approval.

Conclusions:

  • The developed Neurology Therapeutics Committee model addresses key challenges in implementing innovative pediatric neurological therapies.
  • This committee structure promotes personalized, evidence-based, and cost-effective treatment strategies.
  • The committee's approach demonstrates broader applicability for optimizing the use of advanced therapeutics in pediatric care.